Skip to main content
SpringerLink
Log in

The Efficacy of Diuretics in Acute and Chronic Renal Failure

Focus on Torasemide

  • Published:
Drugs Aims and scope Submit manuscript

Summary

Loop diuretics in high doses are the drugs of choice in the treatment of both acute renal failure (ARF) and chronic renal failure (CRF). Their pharmacokinetic and pharmacodynamic properties give them a high efficacy, even in severely compromised renal function. The serum elimination half-life and duration of action of most loop diuretics are dependent on the glomerular filtration rate and are therefore prolonged in renal failure. Torasemide, a new high ceiling and long acting loop diuretic, is as potent as furosemide (frusemide) in patients with advanced renal failure. Unlike other loop diuretics, the half-life and duration of action of torasemide are not dependent on renal function and the parent drug does not accumulate in renal failure. The extent of metabolism is clinically negligible. A number of studies have demonstrated the efficacy of furosemide, bumetanide, piretanide and torasemide in patients with ARF and CRF. When compared with the other loop diuretics, torasemide has the following advantages: a longer half-life independent of renal function, no indications of toxic side effects and apparently less influence on calciuresis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allison MEM, Kennedy AC. Diuretics in chronic renal disease: a study of high dosage furosemide. Clinical Science 41: 171–187, 1971

    PubMed  CAS  Google Scholar 

  • Andreasen F, Hansen HE, Mikkelsen E. Pharmacokinetics of furosemide in anephric patients and in normal subjects. European Journal of Clinical Pharmacology 13: 41–48, 1978

    Article  PubMed  CAS  Google Scholar 

  • Andreucci VE, Russo D, Memoli B, Testa A, Rampino T, et al. Efficacy of IV torasemide in the treatment of acute and chronic high grade renal failure. In Krück et al. (Eds) Torasemide: Clinical Pharmacology and Therapeutic Applications. Progress in Pharmacology and Clinical Pharmacology Vol. 8/1, pp. 229–238, Gustav Fischer Verlag, Stuttgart, 1990

    Google Scholar 

  • Baehler RW, Kotchen TA, Burke JA, Galla JH, Bhathena D. Considerations on the pathophysiology of mercuric chloride-induced renal failure. Journal of Laboratory and Clinical Medicine 90: 330–340, 1977

    PubMed  CAS  Google Scholar 

  • Beall AC, Hall WC, Morris GC, DeBakey ME. Mannitol-induced osmotic diuresis during renal artery occlusion. Annals of Surgery 161: 46–52, 1965

    Article  PubMed  Google Scholar 

  • Beermann B, Groschinsky-Grind M. Clinical pharmacokinetics of diuretics. Clinical Pharmacokinetics 5: 221–245, 1980

    Article  PubMed  CAS  Google Scholar 

  • Benet LZ, Pharmacokinetics/pharmacodynamics of furosemide in man: a review. Journal of Pharmacokinetics and Biopharmaceutics 7: 1–27, 1979

    Article  PubMed  CAS  Google Scholar 

  • Brater DC, Anderson SA, Brown-Cartwright D. Response to furosemide in chronic renal insufficiency: rationale for limited doses. Clinical Pharmacology and Therapy 40: 134–139, 1986

    Article  CAS  Google Scholar 

  • Brater DC, Leinfelder J, Anderson SA. Clinical pharmacology of torasemide, a new loop diuretic. Clinical Pharmacology and Therapeutics 42: 187–192, 1987

    Article  PubMed  CAS  Google Scholar 

  • Brezis M, Rosen S, Silva P, Epstein FH. Transport activity modifies thick ascending limb in the isolated perfused kidney. Kidney International 25: 65–72, 1984

    Article  PubMed  CAS  Google Scholar 

  • Brown CB, Ogg CS, Cameron JS. High dose of furosemide in acute renal failure: a controlled trial. Clinical Nephrology 15: 90–96, 1981

    PubMed  CAS  Google Scholar 

  • Cantarovich F, Galli C, Benedetti L, Chena C, Castro L, et al. Highdose furosemide in established acute renal failure. British Medical Journal 4: 449–450, 1973

    Article  PubMed  CAS  Google Scholar 

  • Clasen W, Khartabil T, Imm S, Kindler J. Torasemide for diuretic treatment of advanced chronic renal failure. Arzneimittel-Forschung 38: 209–211, 1988

    PubMed  CAS  Google Scholar 

  • Cutler RE, Forrey AW, Christopher TG, Kimpel BM. Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clinical Pharmacology and Therapeutics 15: 588–596, 1974

    PubMed  CAS  Google Scholar 

  • Delarge J. Chemistry and pharmacological properties of the pyridine-2-sulfonylurea derivative torasemide. Arzneimittel-Forschung 38: 144–150, 1988

    PubMed  CAS  Google Scholar 

  • De Torrente A, Miller PD, Cronin RE, Paulsin PE, Erickson AL, et al. Effects of furosemide and acetylcholine in norepinephrine-induced renal failure. American Journal of Physiology 235: F131–F136, 1978

    PubMed  Google Scholar 

  • Dodion L, Willems JL. Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency. European Journal of Clinical Pharmacology 31 (Suppl.): 49–51, 1986

    Article  PubMed  Google Scholar 

  • Dupont AG, Gerlo E, Van der Niepen P, Piepsz A, Renal pharmacodynamic effects of torasemide and furosemide in normal man. Arzneimittel-Forschung 38: 172–175, 1988

    PubMed  CAS  Google Scholar 

  • Epstein M, Schneider NS, Befeler B. Effect of intrarenal furosemide on renal function and intrarenal hemodynamics in acute renal failure. American Journal of Medicine 58: 510–516, 1975

    Article  PubMed  CAS  Google Scholar 

  • Fink M. Are diuretics useful in the treatment of prevention of acute renal failure? Southern Medical Journal 75: 329–334, 1982

    Article  PubMed  CAS  Google Scholar 

  • Flamenbaum W, Friedman R. Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new ‘loop’ diuretic. Pharmacotherapy 2: 213–222, 1982

    PubMed  CAS  Google Scholar 

  • Fritz KW, Wilbrandt R, Piehl W, Freyland MD, Freund HW. Long-term high dosage furosemide in chronic renal insufficiency. Postgraduate Medicine 47: 42–44, 1971

    Google Scholar 

  • Goto S, Yoshitomi H, Miyamoto A, Inoue K, Nakano M. Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease. Journal of Pharmacodynamics 3: 667–676, 1980

    Article  CAS  Google Scholar 

  • Grabensee B, Knabe P, Koczy B, Heering P, Achhammer J, et al. Wirkungsvergleich unterschiedlicher oraler Dosen von Torasemid und Furosemid bei chronischer Niereninsuffizienz. Nieren- und Hochdruckkrankheiten 15: 374, 1986

    Google Scholar 

  • Greger R, Schlatter E. Cellular mechanism of the action of loop diuretics on the thick ascending limb of Henle’s loop. Klinische Wochenschrift 61: 1019–1027, 1983

    Article  PubMed  CAS  Google Scholar 

  • Hanley MJ, Davidson K. Prior mannitol and furosemide infusion in a model of ischemic acute renal failure. American Journal of Physiology 241: F556–F564, 1981

    PubMed  CAS  Google Scholar 

  • Higashio T, Abe Y, Yamamoto K. Renal effects of bumetanide. Journal of Pharmacology and Experimental Therapeutics 207: 212–220, 1978

    PubMed  CAS  Google Scholar 

  • Holazo AA, Colburn WA, Gustafson JH, Young RL, Parsonnet M. Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects. Journal of Pharmaceutical Sciences 73: 1108–1113, 1984

    Article  PubMed  CAS  Google Scholar 

  • Huang CM, Atkinson A, Levin N, Quintanilla A. Pharmacokinetics of furosemide in advanced renal failure. Clinical Pharmacology and Therapeutics 16: 659–666, 1974

    PubMed  CAS  Google Scholar 

  • Kampf D, Baethke R. Die diuretische Effektivität von Bumetanid im kontrollierten Vergleich zu Furosemid bei chronischer Niereninsuffizienz unterschiedlichen Schweregrades. Arzneimittel-Forschung 30: 1015–1018, 1980

    PubMed  CAS  Google Scholar 

  • Keller E, Hoppe-Seyler G, Mumm R, Schollmeyer P. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide. European Journal of Clinical Pharmacology 20: 27–33, 1981

    Article  PubMed  CAS  Google Scholar 

  • Kirsten R, Rietbrock I, Huber TD, Heintz B, Nelson K, et al. Influence of piretanide on vasoactive prostaglandins, catecholamines, renin and aldosterone in patients with acute renal failure. In Puschett & Greenberg (Eds) Diuretics III: chemistry, pharmacology and clinical applications. Elsevier Science Publishing Company, New York, 1990

    Google Scholar 

  • Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure: a controlled trial. Nephron 17: 51–58, 1976

    Article  PubMed  CAS  Google Scholar 

  • Klütsch K, Grosswendt J, Haecker W. Single dose comparison of torasemide and furosemide in patients with advanced renal failure. Arzneimittel-Forschung 38: 200–204, 1988

    PubMed  Google Scholar 

  • Knauf H, Spahn H, Rücker H-M, Mutschier E. The loop diuretic torasemide in renal failure. Kinetics and dynamics. In Krück et al. (Eds) Torasemide: Clinical Pharmacology and Therapeutic Applications. Progress in Pharmacology and Clinical Pharmacology Vol. 8/1, pp. 81–93, Gustav Fischer Verlag, Stuttgart, 1990

    Google Scholar 

  • Krämer BK, Risler T. Xipamide. Cardiovascular Drug Reviews 6: 141–154, 1988

    Article  Google Scholar 

  • Kult J, Hacker W, Glocke M. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure. Arzneimittel-Forschung 38: 212–214, 1988

    PubMed  CAS  Google Scholar 

  • Kult J, Ziegler J, von Möllendorff E. Pharmacodynamics and pharmacokinetics of torasemide and furosemide in patients with high grade renal failure after application of high intravenous doses. In Krück et al. (Eds) Torasemide: Clinical Pharmacology and Therapeutic Applications. Progress in Pharmacology and Clinical Pharmacology Vol. 8/1, pp. 239–248, Gustav Fischer Verlag, Stuttgart, 1990

    Google Scholar 

  • Lau HSH, Heyneck ML, Berardi RR, Swartz RD, Smith DE. Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with chronic renal failure. Clinical Pharmacology and Therapeutics 39: 635–645, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lesne M. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers. Arzneimittel-Forschung 38: 160–163, 1988

    PubMed  CAS  Google Scholar 

  • Levine SD. Diuretics. Medical Clinics of North America 73: 271–282, 1989

    PubMed  CAS  Google Scholar 

  • Loute G, Adam A, Ers P, Heremans C, Willems B. The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure. European Journal of Clinical Pharmacology 31 (Suppl.): 53–55, 1986

    Article  PubMed  Google Scholar 

  • Mackay IG, Muir AL, Watson ML. Contribution of prostaglandins to the systemic and renal vascular response to furosemide in normal man. British Journal of Clinical Pharmacology 17: 513–519, 1984

    Article  PubMed  CAS  Google Scholar 

  • Maharaj B. Diuretics in renal failure. Progress in Pharmacology 6: 267–288, 1988

    Google Scholar 

  • Marcantonio LA, Auld WHR, Murdoch WR, Purohit R, Skellern GG, et al. The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease. British Journal of Clinical Pharmacology 15: 245–252, 1983

    Article  PubMed  CAS  Google Scholar 

  • Marone C, Reubi FC, Perisic M, Lahn W. Pharmacokinetics of high doses of piretanide in moderate to severe renal failure. European Journal of Clinical Pharmacology 27: 589–593, 1984

    Article  PubMed  CAS  Google Scholar 

  • Minuth AN, Terrell JB, Suki WN. Acute renal failure: a study of the course and prognosis of 104 patients and of the role of furosemide. American Journal of Medical Sciences 271: 317–324, 1976

    Article  CAS  Google Scholar 

  • Mourad G, Haecker W, Mion C. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure. Arzneimittel-Forschung 38: 205–208, 1988

    PubMed  CAS  Google Scholar 

  • Neugebauer G, Besenfelder E, von Möllendorff E. Pharmacokinetics and metabolism of torasemide in man. Arzneimittel-Forschung 38: 164–166, 1988

    PubMed  CAS  Google Scholar 

  • Oberleithner H, Giebisch G, Lang F, Wang W. Cellular mechanism of the furosemide sensitive transport system in the kidney. Klinische Wochenzeitschrift 60: 1173–1179, 1982

    Article  CAS  Google Scholar 

  • Pentikaäinen PJ, Pasternack A, Lampainen E, Neuvonen PJ, Penttilä A. Bumetanide kinetics in renal failure. Clinical Pharmacology and Therapeutics 37: 582–588, 1985

    Article  Google Scholar 

  • Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, et al. Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clinical Pharmacology and Therapeutics 24: 199–207, 1978

    PubMed  CAS  Google Scholar 

  • Risler T, Hellstern K, Ress K, Achhammer A, Häcker W, et al. Torasemid bei chronischer Niereninsuffizienz. Nieren- und Hochdruckkrankheiten 15: 527–528, 1986

    Google Scholar 

  • Rodrigo F, Shideman J, McHugh R, Buselmeier T, Kjellstrand C. National history, clinical correlations and influence of dialysate glucose and intravenous mannitol. Annals of Internal Medicine 86: 554–561, 1977

    PubMed  CAS  Google Scholar 

  • Russo D, Gazzotti MR, Testa A. Torasemide, a new loop diuretic in patients with chronic renal failure. Nephron 55: 141–145, 1990

    Article  PubMed  CAS  Google Scholar 

  • Schmidt P, Loew D, Dycka J, Kopsa H, Balcke P, et al. Comparison of the effects of muzolimine and furosemide in patients with end-stage renal failure and chronic dialysis. European Journal of Clinical Pharmacology 20: 23–26, 1981

    Article  PubMed  CAS  Google Scholar 

  • Schulz W, Dörfler A, Stiehl L, Achhammer I. Double blind clinical trial investigating the efficacy and long-term tolerance of torasemide 200mg p.o. compared with furosemide 500mg p.o. and placebo p.o. in patients with chronic renal failure on hemodialysis — a multicentre study. In Krück et al. (Eds) Torasemide: Clinical Pharmacology and Therapeutic Applications. Progress in Pharmacology and Clinical Pharmacology Vol. 8/ 1, pp. 249–257, Gustav Fischer Verlag, Stuttgart, 1990

    Google Scholar 

  • Stolear IC, Achhammer I, Georges B. Efficacy of torasemide in the treatment of patients with high-grade renal failure on dialysis. Progress in Pharmacology and Clinical Pharmacology Vol. 8/1, pp. 259–267, Gustav Fischer Verlag, Stuttgart, 1990

    Google Scholar 

  • Stroobandt R, Dodion L, Kaesteloot H. Clinical efficacy of torasemide, a new direutic agent, in patients with acute heart failure: a double blind comparison with furosemide. Archives of International Pharmacodynamics 260: 151–158,1982

    CAS  Google Scholar 

  • Tiller DJ, Mudge GH. Pharmacologic agents used in the management of acute renal failure. Kidney International 18: 700–711, 1980

    Article  PubMed  CAS  Google Scholar 

  • Tilstone WJ, Fine A. Furosemide kinetics in renal failure. Clinical Pharmacology and Therapeutics 23: 644–650, 1978

    PubMed  CAS  Google Scholar 

  • Walter U, Röckel A, Lahn W, Heidland A, Heptner W. Pharmacokinetics of the loop diuretic piretanide in renal failure. European Journal of Clinical Pharmacology 29: 337–343, 1985

    Article  PubMed  CAS  Google Scholar 

  • Wollam GL, Tarazi RC, Bravo EL, Dustan HP. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. American Journal of Medicine 72: 929–938, 1982

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Nephrology and Hypertension, Department of Medicine III, University of Tübingen, Otfried-Müller-Strasse 10, 74, Tübingen, Germany

    T. Risler, B. Krämer & G. A. Müller

Authors
  1. T. Risler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Krämer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. A. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Risler, T., Krämer, B. & Müller, G.A. The Efficacy of Diuretics in Acute and Chronic Renal Failure. Drugs 41 (Suppl 3), 69–79 (1991). https://doi.org/10.2165/00003495-199100413-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199100413-00008

Keywords

Search

Navigation